| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | US20100011470 Methods and means of increasing the water use efficiency of plants |
| 01/14/2010 | US20100011469 Tissue specific regulatory sequences for targeting protein expression in plant reproductive tissue |
| 01/14/2010 | US20100011468 Fungus resistant plants and their uses |
| 01/14/2010 | US20100011467 Method for increasing resistance to pathogens in transgenic plants |
| 01/14/2010 | US20100011466 Signal Transduction Stress-Related Proteins and Methods of Use in Plants |
| 01/14/2010 | US20100011465 Protein Kinase Stress-Related Polypeptides and Methods of Use in Plants |
| 01/14/2010 | US20100011464 Plants having enhanced yield-related traits and a method for making the same |
| 01/14/2010 | US20100011463 Compositions and Methods Using RNA Interference for Control of Nematodes |
| 01/14/2010 | US20100011462 Flavin monooxygenases and transcription factors involved in glucosinolate biosynthesis |
| 01/14/2010 | US20100011461 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 01/14/2010 | US20100011460 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/14/2010 | US20100011458 Sweet pepper line sbr28-1220 |
| 01/14/2010 | US20100011457 Sweet pepper line sbr28-1244 |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011455 Stem cell gene targeting |
| 01/14/2010 | US20100011454 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/14/2010 | US20100011453 Model for muscular dystrophy and cardiomyopathy |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010206 siRNA Targeting Hypoxia-Inducible Factor 1 |
| 01/14/2010 | US20100010202 Human antibodies derived from immunized xenomice |
| 01/14/2010 | US20100010201 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 01/14/2010 | US20100010200 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 01/14/2010 | US20100010196 Compositions and methods for non-targeted activation of endogenous genes |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100010073 Microrna (mirna) for the diagnosis and treatment of heart diseases |
| 01/14/2010 | US20100010071 Compositions and use of EPAS1 inhibitors |
| 01/14/2010 | US20100010070 Use of nucleic acid sequences for the treatment of neuralogical and psychiatric diseases and compositions |
| 01/14/2010 | US20100010068 Liver-directed gene therapy |
| 01/14/2010 | US20100010067 Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery system |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009898 Protease resistant insulin analogues |
| 01/14/2010 | US20100009866 Surface Display of Whole Antibodies in Eukaryotes |
| 01/14/2010 | US20100009863 Method for engineering t-cell receptors |
| 01/14/2010 | US20100009861 Breast cancer prognostics |
| 01/14/2010 | US20100009857 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/14/2010 | US20100009856 Randomized dna libraries and double-stranded rna libraries, use and method of production thereof |
| 01/14/2010 | US20100009851 Plant regulatory sequences |
| 01/14/2010 | US20100009451 Compositions and methods for specifically silencing a target nucleic acid |
| 01/14/2010 | US20100009450 Method for cloning and expressing target gene by homologous recombination |
| 01/14/2010 | US20100009446 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
| 01/14/2010 | US20100009441 Polynucleotides encoding anti-sulfotyrosine antibodies |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009438 Dendritic cell potentiation |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009435 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
| 01/14/2010 | US20100009434 Method for the Selective Enrichment of Double-Stranded Dna from Nucleic Acid Mixtures |
| 01/14/2010 | US20100009432 Conductive carbon nanotubes dotted with metal and method for fabricating a biosensor using the same |
| 01/14/2010 | US20100009426 synthetic or recombinant polypeptide having a nitrilase activity; have increased activity and stability at increased pH and temperature |
| 01/14/2010 | US20100009423 B. braunii, race b gene for a triterpene methyltransferase enzyme and uses thereof |
| 01/14/2010 | US20100009420 Genetic Modification of Homolactic Thermophilic Bacilli |
| 01/14/2010 | US20100009413 Nucleic acid molecules encoding alternansucrase |
| 01/14/2010 | US20100009410 Methods and Constructs for Expressing Polypeptide Multimers in Eukaryotic Cells Using Alternative Splicing |
| 01/14/2010 | US20100009409 Molecular variant fibrinogen fusion proteins |
| 01/14/2010 | US20100009406 Gene sequence coding formyl peptide receptor binding protein; diagnosing cancer, wound bone healing, obesity, acute heart failure, hypotension, hypertension, urinary retention, osteoporosis, restenosis, atherosclerosis, thrombosis, cardiovascular, autoimmune and nervous system disorders |
| 01/14/2010 | US20100009404 Production of beta-lactam antibiotics |
| 01/14/2010 | US20100009384 Acyltransferase -1 (ACTR-1); for identifying modulators or are useful themselves as compositions for diagnosis and treatment of disease or disorder that arise from malfunction of the regulation of triacylglycerol (triglyceride) and phospholipid biosynthesis e.g. atherosclerosis; cardiovascular disorders |
| 01/14/2010 | US20100009382 Methods and compositions for diagnosing lung cancer |
| 01/14/2010 | US20100009377 Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases |
| 01/14/2010 | US20100009366 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 01/14/2010 | US20100009365 Process for high-throughput dna methylation analysis |
| 01/14/2010 | US20100009341 Methods and means for assessing hiv gag/protease inhibitor therapy |
| 01/14/2010 | US20100009062 Soybean Cultivar 397.TLC |
| 01/14/2010 | US20100008981 Methods and sequences to suppress primate huntington gene expression |
| 01/14/2010 | US20100008977 Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseases |
| 01/14/2010 | US20100008952 Vaccines for the Rapid Response to Pandemic Avian Influenza |
| 01/14/2010 | US20100008949 Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 01/14/2010 | US20100008947 Porcine adenovirus e1 and e4 regions |
| 01/14/2010 | US20100008946 Microorganisms for therapy |
| 01/14/2010 | US20100008945 Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus |
| 01/14/2010 | US20100008944 Herpes simplex virus mutant and uses therefore |
| 01/14/2010 | US20100008941 vaccination directed against the hepatitis C virus (HCV); |
| 01/14/2010 | US20100008939 Unprocessed rolling circle amplification product |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008919 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to inhibit angiogenesis that accompanies tumor development |
| 01/14/2010 | US20100008906 Cripto binding molecules |
| 01/14/2010 | US20100008905 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 01/14/2010 | US20100008900 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 01/14/2010 | US20100008895 used in vaccines against A. salmonicida infections such as fish disease furunculosis; ADP-ribosylating toxins |
| 01/14/2010 | US20100008889 Adenoviral expression vectors |
| 01/14/2010 | US20100008871 New Biochemical Route to Astaxanthin |
| 01/14/2010 | US20100008853 Anti ganglioside gd3 antibodies and uses thereof |
| 01/14/2010 | US20100008851 Anti-gd2 antibodies and methods and uses related thereto |
| 01/14/2010 | US20100006437 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| 01/14/2010 | DE102008040352A1 Verfahren zur Herstellung von L-Tryptophan unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae A method for producing L-tryptophan using the improved strains of the family Enterobacteriaceae |
| 01/14/2010 | CA2766828A1 Methods and compositions for promoting bone growth |
| 01/14/2010 | CA2733353A1 Wheat starch and wheat flours and foodstuffs containing these wheat starch/wheat flours |
| 01/14/2010 | CA2733119A1 Recombinant expression vector for animal cell |
| 01/14/2010 | CA2730408A1 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | CA2730300A1 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | CA2730243A1 Surface display of whole antibodies in eukaryotes |
| 01/14/2010 | CA2730201A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | CA2730185A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | CA2730171A1 Soluble recombinant influenza antigens |
| 01/14/2010 | CA2730152A1 Enzymes and methods for hydrolysing phenylureas, carbamates and organophosphates |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2729949A1 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |